FINHUB Insights

DGX · Q3 FY24 · Jul 1 – Sep 30, 2024

Quest Diagnostics Q3 FY24: where the revenue came from and where it went

Quest Diagnostics Q3 FY24: revenue $2.5B (+8% year over year). Net profit $0.2B. Largest cohort Diagnostic Information $2.4B. The whole income statement as a sankey diagram from the SEC filing.

Period
Jul 1 – Sep 30, 2024
Reported
Oct 23, 2024 10-Q
Sankey diagram of Quest Diagnostics's income statement for Q3 FY24: revenue of $2.5 billion splits into segments and flows out into costs, taxes and net profit.

Tap the diagram to enlarge · figures in billions of dollars

Revenue$2.5B +8% year over year
Gross profit$0.8B 33% margin
Operating profit$0.3B 13% margin
Net profit$0.2B 9% margin

The numbers

All figures in billions of U.S. dollars, for Q3 FY24 (period ends Sep 30, 2024).
ItemValueShare of revenueYear over year
Revenue 2.5 100% +8%
Diagnostic Information 2.4 96% +9%
All Other Segments 0.1 4% −9%
Cost of revenue−1.768%
Gross profit0.833% margin+0pp
SG&A−0.418%+1pp
Other−01%+0pp
Operating profit0.313% margin−2pp
Tax−0.1
Net profit0.29%−1pp
Filing on EDGAR More quarters of DGX

Source of the numbers: structured XBRL data from the filing (10-Q). The diagram is generated automatically and checked against EDGAR before release. How we calculate it → About and methodology.

Older quarters